Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 26.26% and Operating profit at -237.77% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Risky -
3
Underperformed the market in the last 1 year
Stock DNA
Chemicals & Petrochemicals
CNY 2,678 Million (Mid Cap)
NA (Loss Making)
NA
0.00%
-2.57
200.79%
-14.94
Revenue and Profits:
Net Sales:
118 Million
(Quarterly Results - Mar 2026)
Net Profit:
-64 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.02%
0%
-14.02%
6 Months
-17.72%
0%
-17.72%
1 Year
-33.4%
0%
-33.4%
2 Years
100.62%
0%
100.62%
3 Years
-22.06%
0%
-22.06%
4 Years
-55.84%
0%
-55.84%
5 Years
-41.34%
0%
-41.34%
Ningxia Zhongke Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
26.26%
EBIT Growth (5y)
-237.77%
EBIT to Interest (avg)
-2.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
32.15
Sales to Capital Employed (avg)
0.53
Tax Ratio
0.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-26.65
EV to EBIT
-9.51
EV to EBITDA
-14.49
EV to Capital Employed
4.46
EV to Sales
8.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-46.94%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
117.70
117.10
0.51%
Operating Profit (PBDIT) excl Other Income
-57.40
-176.90
67.55%
Interest
2.20
4.60
-52.17%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-63.80
118.80
-153.70%
Operating Profit Margin (Excl OI)
-487.70%
-1,785.00%
129.73%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.51% vs 4.74% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -153.70% vs 228.99% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
443.70
336.30
31.94%
Operating Profit (PBDIT) excl Other Income
-196.90
-81.40
-141.89%
Interest
27.50
145.40
-81.09%
Exceptional Items
205.50
-44.00
567.05%
Consolidate Net Profit
-162.90
-577.00
71.77%
Operating Profit Margin (Excl OI)
-729.60%
-617.00%
-11.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 31.94% vs 18.08% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 71.77% vs -11.80% in Dec 2024
About Ningxia Zhongke Biotechnology Co., Ltd. 
Ningxia Zhongke Biotechnology Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






